Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma.

Jordan J JonesHong NguyenStephen Q WongJames WhittleJosie IariaStanley StylliJames TownerThomas PietersFrank GaillardAndrew H KayeKatharine J DrummondAndrew P Morokoff

Published in: Neuro-oncology advances (2024)

mutations in glioma patients. Total cfDNA may also assist with prognostic information. Further studies are needed to validate these findings and the clinical role of ctDNA in glioma.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
circulating tumor
healthcare
patient reported outcomes
health information
case control
fine needle aspiration